Emmaus Life Sciences
Financial ratios & Valuation

Historical Multiples (2013 – 2021)

2013 2014 2015 2016 2017 2018 2019 2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
N/A-1.38-1.09-0.62-0.51-0.35-0.063.35-0.23-201.07-0.43
Price/Sales ratio
N/A27.3436.9043.4028.742.800.160.150.17155.5736.07
Price/Book Value ratio
N/A-2.09-0.76-14.400.810.91-0.33-0.68-0.17-149.480.86
Price/Cash Flow ratio
N/A-1.12-1.74-1.24-0.77-0.40-0.81-1.50-2.94-2.55K-0.58
Price/Free Cash Flow ratio
N/A-1.12-1.74-1.20-0.75-0.40-0.80-0.12-2.94-2.55K-0.57
Price/Earnings Growth ratio
N/A0.01-0.04-0.00-0.03-0.00-0.00-0.030.000.00-0.01
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
-8.93%45.96%95.10%93.53%58.36%37.10%95.19%90.29%83.93%83.93%75.95%
Operating Profit Margin
-7347.89%-1967.13%-3113.88%-3780.72%-5528.09%-722.95%-119.92%19.01%-62.20%-29.73%-4654.41%
Pretax Profit Margin
-8317.18%-1965.13%-3377.62%-6978.73%-5533.22%-785.34%-240.32%3.10%-77.24%-77.24%-6255.98%
Net Profit Margin
-8317.79%-1968.98%-3382.61%-6981.08%-5535.25%-785.48%-241.04%4.74%-77.37%-77.37%-6258.16%
Effective Tax Rate
-0.00%-0.19%-0.14%-0.03%-0.03%-0.01%-0.29%-52.99%-0.15%-0.15%-0.02%
Return on Assets
-776.49%-199.09%-597.07%-450.03%-116.67%-200.57%-92.23%1.85%-28.10%-28.10%-283.35%
Return On Equity
504.07%151.00%70.00%2316.14%-156.41%-256.98%496.17%-20.29%74.34%108.84%1079.86%
Return on Capital Employed
446.53%946.77%158.45%1459.80%-156.09%-238.57%-102.46%12.27%-65.29%-31.21%-93.65%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/A1.250.48N/A0.24N/A
Quick Ratio
0.360.800.210.783.683.011.010.170.120.083.34
Cash ratio
0.350.760.170.203.522.790.050.100.060.063.15
Days of Sales Outstanding
74.1725.1243.0221.87471.5117.5634.493.1118.4118.41244.54
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/A2.65K1.15K484.02484.02N/A
Operating Cycle
74.1725.1243.0221.87471.5117.562.69K1.15K502.43488.56246.69
Days of Payables Outstanding
6.38K4.34K63.46K28.31K5.02K153.032.42K328.46N/AN/A2.59K
Cash Conversion Cycle
-6.30K-4.31K-63.42K-28.28K-4.55K-135.46266.03825.34502.43137.76-16.42K
Debt Ratios
Debt Ratio
2.541.104.880.070.000.110.320.320.201.370.03
Debt Equity Ratio
-1.64-0.84-0.57-0.360.000.14-1.76-3.50-0.55-3.640.07
Long-term Debt to Capitalization
-0.00-5.21-1.33-0.160.000.12-0.554.80-0.20-0.200.06
Total Debt to Capitalization
-0.00-5.29-1.33-0.570.000.122.311.39-1.24-1.240.06
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/A-0.16-0.00N/A-1.97N/A
Cash Flow to Debt Ratio
-230.01-2.20-0.76-31.82-132.37-15.29-0.23-0.12-0.10-0.10-82.09
Company Equity Multiplier
-0.64-0.75-0.11-5.141.341.28-5.37-10.93-2.64-2.641.31
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-23.19-24.21-21.12-34.99-37.29-6.87-0.19-0.10-0.06-0.06-36.14
Free Cash Flow / Operating Cash Flow Ratio
1111.021.021.001.0111.671.001.001.01
Cash Flow Coverage Ratio
-230.01-2.20-0.76-31.82-132.37-15.29-0.23-0.12-0.10-0.10-82.09
Short Term Coverage Ratio
-421.69-934.6-881.16-51.79-146.10-6.95K-0.29-0.20-0.15-0.15-98.94
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A